Skip to content
October 24, 2022

Elizabeth Stoner, M.D.

Dr. Elizabeth (Liz) Stoner is an Entrepreneur Partner at MPM BioImpact. Liz is a Senior Clinical Advisor of AlloVir (NASDAQ: ALVR), a subsidiary of portfolio company ElevateBio, and was most recently the company’s interim CMO. She also serves as Senior Clinical Advisor to Rhythm Pharmaceuticals (NASDAQ: RYTM). Liz is a distinguished biopharma executive, who brings decades of international industry experience to her role guiding and growing MPM BioImpact portfolio companies.

Liz has held several leadership roles at MPM BioImpact portfolio companies including interim CEO of Semma Therapeutics; founder, CMO and Chief Development Officer (CDO) of Rhythm and the CDO of Vascular Pharmaceuticals. She also served in clinical and advisory roles at Clinical Ink, Potenza Therapeutics, Solasia and TriNetX. Liz is a member of the Cures Acceleration Network Review Board of the National Center for Advisory Translations Sciences of the NIH to represent viewpoints of drug development and venture capital professionals regarding the discovery and development of therapeutics, diagnostics and devices.

Prior to joining MPM BioImpact, Liz was Senior Vice President of Global Clinical Development Operations at Merck Research Laboratories where she was responsible for its clinical development activities in more than 40 countries. While at Merck, she also oversaw the clinical development activities of its Japanese subsidiary and played a leading role in Merck/Schering Plough Joint Venture’s development of Vytorin and Zetia, blockbuster cholesterol lowering drugs. Previously, she led the 5-alpha reductase clinical development program, establishing Merck as a leader in the field of prostate disease. As Endocrine Therapeutic Head at Merck, her responsibilities included all steroid and lipid metabolism, as well as the bisphosphonate and growth hormone secretagogue clinical research programs. Prior to joining the biopharma industry, she was an Assistant Professor of Pediatrics at Cornell University Medical College. Liz currently serves on the boards of Vascular Pharmaceuticals and Momenta Pharmaceuticals. She is also a member of the Albert Einstein College of Medicine Board of Governors, and the Weill Cornell Medical College Clinical and Translational Science Center External Advisory Board.

Liz received her M.D. from the Albert Einstein College of Medicine, her M.S. in Chemistry from SUNY at Stony Brook and her B.S. in Chemistry from Ottawa University, KS.